CN Patent

CN117338709B — 一种复方匹可硫酸钠口服溶液及其制备方法

Assigned to Hangzhou Muyuan Biomedical Technology Co ltd · Expires 2025-08-22 · 1y expired

What this patent protects

本发明涉及制药技术领域，具体涉及一种复方匹可硫酸钠口服溶液及其制备方法。所述口服溶液包括如下组分：匹可硫酸钠、无水枸橼酸、氧化镁、稳定剂、抑菌剂和pH调节剂，所述抑菌剂包括羟苯甲酯和羟苯丙酯，两者质量比为15:1‑6:1。本发明具有稳定性高、抑菌效力好的优点。

USPTO Abstract

本发明涉及制药技术领域，具体涉及一种复方匹可硫酸钠口服溶液及其制备方法。所述口服溶液包括如下组分：匹可硫酸钠、无水枸橼酸、氧化镁、稳定剂、抑菌剂和pH调节剂，所述抑菌剂包括羟苯甲酯和羟苯丙酯，两者质量比为15:1‑6:1。本发明具有稳定性高、抑菌效力好的优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN117338709B
Jurisdiction
CN
Classification
—
Expires
2025-08-22
Drug substance claim
No
Drug product claim
No
Assignee
Hangzhou Muyuan Biomedical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.